Scarica l'app Stockscreener
1.36
2.26%
0.03
Dopo l'orario di chiusura:
1.37
0.01
+0.74%
Precedente Chiudi:
$1.33
Aprire:
$1.33
Volume 24 ore:
412.07K
Relative Volume:
0.30
Capitalizzazione di mercato:
$25.93M
Reddito:
-
Utile/perdita netta:
$-11.24M
Rapporto P/E:
-1.7859
EPS:
-0.7615
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
+4.62%
1M Prestazione:
-0.73%
6M Prestazione:
+38.78%
1 anno Prestazione:
+4.62%
Intervallo 1D:
$1.31
$1.38
Intervallo di 1 settimana:
$1.29
$1.38
Portata 52W:
$0.73
$2.56
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Nome
Mira Pharmaceuticals Inc
Settore
Industria
Telefono
813-369-5150
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Confronta MIRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.36 | 25.36M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
763.00 | 651.28B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
185.42 | 437.40B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
231.54 | 394.23B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
128.24 | 240.24B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
83.93 | 196.28B | 63.43B | 16.42B | 14.72B | 6.49 |
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
Is MIRA Pharmaceuticals Inc. a candidate for recovery play2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com
MIRA Pharmaceuticals Completes SKNY Acquisition - TipRanks
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals - citybiz
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction - ACCESS Newswire
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com India
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com South Africa
30% Weight Loss: MIRA Pharma Acquires Novel Obesity Drug SKNY-1 That Also Treats Nicotine Addiction - Stock Titan
Mira Pharmaceuticals completes acquisition of SKNY Pharmaceuticals - Investing.com
What data driven models say about MIRA Pharmaceuticals Inc.’s futureJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Can MIRA Pharmaceuticals Inc. stock surprise with earnings upside2025 Analyst Calls & Fast Moving Market Watchlists - newser.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Advances Neuroscience Research - Kalkine Media
Is MIRA Pharmaceuticals Inc. stock a buy in volatile marketsWatch List & Safe Capital Investment Plans - newser.com
How to interpret RSI for MIRA Pharmaceuticals Inc. stockTrade Ideas & Risk Managed Investment Entry Signals - newser.com
What moving averages say about MIRA Pharmaceuticals Inc.Weekly Investment Recap & Technical Pattern Based Signals - newser.com
Using fundamentals and technicals on MIRA Pharmaceuticals Inc.2025 Institutional Moves & Community Consensus Picks - newser.com
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Augusta Chronicle
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - The Daily Jeffersonian
Custom strategy builders for tracking MIRA Pharmaceuticals Inc.Trade Volume Report & Daily Market Momentum Tracking - newser.com
What drives MIRA Pharmaceuticals Inc stock priceStraddle and Strangle Trades & Small Entry Cost Investments - earlytimes.in
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation - Sarasota Herald-Tribune
What indicators show strength in MIRA Pharmaceuticals Inc.July 2025 Drop Watch & Real-Time Volume Analysis - newser.com
What analysts say about MIRA Pharmaceuticals Inc stockMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Is MIRA Pharmaceuticals Inc. stock overvalued by current metricsJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - Sarasota Herald-Tribune
Can MIRA Pharmaceuticals Inc. stock sustain free cash flow growthBear Alert & Momentum Based Trading Signals - newser.com
How MIRA Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Macro Moves & Safe Entry Trade Reports - The British Mountaineering Council
Analyzing MIRA Pharmaceuticals Inc. with multi timeframe chartsEarnings Trend Report & Growth Focused Stock Pick Reports - newser.com
MIRA Pharmaceuticals reports positive Phase 1 results for pain drug By Investing.com - Investing.com Nigeria
MIRA Pharmaceuticals reports positive Phase 1 results for pain drug - Investing.com India
Published on: 2025-09-22 12:43:38 - newser.com
MIRA Pharmaceuticals Reports Positive Phase 1 Study Results - TipRanks
Mira Pharmaceuticals reports positive Phase 1 results for Ketamir-2 trial - Investing.com Canada
Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.40%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):